Anti-IFNB1, AlpHcAbs® Human antibody

Anti-IFNB1, AlpHcAbs® Human antibody
Anti-IFNB1, AlpHcAbs® Human antibody

Details and Advantages

Code: 300-643-001

Specification:

Applications: ELISA,Flow Cyt

Reactivity: Human

Conjugate: Unconjugated

Advantages:

High lot-to-lot consistency Increased sensitivity and higher affinity Animal-free production

Product Detail

Product Detail

Description:
Anti-IFNB1, AlpHcAbs® Human antibody is designed for detecting human IFNB1 specifically. Based on ELISA and/or FCM, Anti-IFNB1, AlpHcAbs® Human antibody reacts with human IFNB1 specifically.

Immunogen: Recombinant human IFNB1
Host: Alpaca pacous
Isotype: Human IgG1
Conjugate: Unconjugated
Specificity: Human IFNB1
Purity: Recombinant Expression and Affinity purified
Concentration: 1mg/ml
Formation: Liquid, 10mM PBS (pH 7.5), 0.05% sucrose, 0.1% trehalose, 0.01% proclin300, 50% Glycerol
Storage: Store at –20 °C, (Avoid freeze / thaw cycles)

Background:
Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by Natural IFN-producing cells (IPCs) as part of the host immune response. IFNs can also inhibit the development of tumors. IFN-beta binding results in the activation of the tyrosine kinases Jak1 and Tyk2, phosphorylation of members of the STAT family of transcription factors, and the transcription and expression of the immune response genes. More recently, several members of the toll-like receptor (TLR) family were found to stimulate the production IFN-beta. IFN-beta is currently used clinically for treatment of tumors, infections and multiple sclerosis.

FAQ

Citations

Related Products

Consult

Contact

Telephone:

+86 138 8067 6215

Address:

Building 16, No.99 Haiwang Road, Wenjiang, Chengdu, China 611130